Kaiser Health News
Listen: Mifepristone Remains Available for Now. What Happens Next?
by
Mon, 24 Apr 2023 22:45:30 +0000
The Supreme Court has ruled that the abortion pill mifepristone should remain widely available for now, a decision that maintains access to the drug while the lower courts consider the issue. Julie Rovner, KFF Health News’ chief Washington correspondent, appeared on NPR’s “Weekend All Things Considered” to explain the complicated, even contradictory court decisions surrounding mifepristone and what they mean for patients and providers.
On April 21, the justices sent back to the 5th Circuit Court of Appeals the case challenging the FDA’s decades-old approval of mifepristone. The appeals court previously ruled the drug could remain on the market, but it required the FDA to reinstate restrictions that had been relaxed in 2016 due to newer evidence about the drug’s safety and efficacy.
Rovner said one major outstanding question is whether that ruling would ban the generic version of mifepristone, which was not approved until 2019 — and is used in many more abortions in the United States than the drug’s brand-name version.
The case has implications well beyond abortion, as mifepristone is used to treat people experiencing miscarriages. The drug industry and others have sounded the alarm that overturning the FDA’s approval of the drug would open the door to lawsuits challenging other controversial drugs, granting judges with no scientific or medical training the power to overrule the FDA.
Read Rovner’s past coverage of the fight over abortion access. And listen to episodes of “What the Health?” — KFF Health News’ weekly policy podcast hosted by Rovner.
Title: Listen: Mifepristone Remains Available for Now. What Happens Next?
Sourced From: kffhealthnews.org/news/article/listen-mifepristone-abortion-pill-fate-confusion/
Published Date: Mon, 24 Apr 2023 22:45:30 +0000
Did you miss our previous article…
https://www.biloxinewsevents.com/us-officials-want-to-end-the-hiv-epidemic-by-2030-many-stakeholders-think-they-wont/
Kaiser Health News
In Settling Fraud Case, New York Medicare Advantage Insurer, CEO Will Pay up to $100M
SUMMARY: Independent Health Association of Buffalo and Betsy Gaffney, CEO of medical analytics firm DxID, have agreed to a settlement of up to $100 million to resolve Justice Department allegations of fraudulent Medicare billing for exaggerated or non-existent health conditions. Independent Health will pay up to $98 million, while Gaffney will contribute $2 million. Neither party admitted wrongdoing. The case was triggered by whistleblower Teresa Ross, highlighting issues of “upcoding” in Medicare Advantage plans. Ross, having faced repercussions for her allegations, will receive at least $8.2 million from the settlement. This case underscores the challenges of regulating billing practices in the Medicare system.
The post In Settling Fraud Case, New York Medicare Advantage Insurer, CEO Will Pay up to $100M appeared first on kffhealthnews.org
Kaiser Health News
Employers Press Congress To Cement Health Price Transparency Before Trump’s Return
SUMMARY: Despite regulations requiring hospitals and insurers to disclose negotiated prices for healthcare services, the impact on consumer costs remains unclear nearly four years later. While the Trump administration’s initial rules and Biden’s enhancements aimed to streamline this data, compliance is inconsistent; a 2022 audit found only 63 out of 100 hospitals met requirements. Some lawmakers proposed legislation to protect these regulations amid uncertainty about Trump’s potential return to office, but efforts fell short. Experts note the complexity of the data often leaves consumers struggling to understand their actual costs, emphasizing the need for improved transparency and enforcement to facilitate informed healthcare choices.
The post Employers Press Congress To Cement Health Price Transparency Before Trump’s Return appeared first on kffhealthnews.org
Kaiser Health News
He Went in for a Colonoscopy. The Hospital Charged $19,000 for Two.
SUMMARY: Tom Contos, a 45-year-old runner, sought a colonoscopy due to ongoing rectal bleeding. His insurance covered part of the procedure, but he was shocked by the final bill of $19,206, which included charges for two colonoscopies. Despite an initial estimate of $7,203, the charges were much higher due to multiple procedures and biopsies. Contos appealed the charges, but Northwestern Medicine maintained that the billing was correct. Health experts suggest patients consider alternatives like ambulatory surgery centers for lower costs. Transparency and clear pricing are key to avoiding unexpected medical expenses.
The post He Went in for a Colonoscopy. The Hospital Charged $19,000 for Two. appeared first on kffhealthnews.org
-
News from the South - Arkansas News Feed6 days ago
Faith-inspired ministry opens health clinic in Little Rock
-
News from the South - Florida News Feed5 days ago
‘Dirty Dancing,’ ‘Beverly Hills Cop,’ ‘Up in Smoke’ among movies entering the National Film Registry
-
Our Mississippi Home5 days ago
The Meaning of the Redbird During the Holiday Season
-
Mississippi Today4 days ago
Mississippi PERS Board endorses plan decreasing pension benefits for new hires
-
Local News1 day ago
Hard Rock Hotel & Casino Biloxi Honors Veterans with Wreath-Laying Ceremony and Holiday Giving Initiative
-
News from the South - Missouri News Feed2 days ago
Could prime Albert Pujols fetch $1 billion in today's MLB free agency?
-
News from the South - North Carolina News Feed1 day ago
Social Security benefits boosted for millions in bill headed to Biden’s desk • NC Newsline
-
Mississippi Today6 days ago
On this day in 1976